Literature DB >> 18025846

Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.

Hideaki Miyake1, Toshifumi Kurahashi, Atsushi Takenaka, Isao Hara, Masato Fujisawa.   

Abstract

INTRODUCTION: The objective of this study was to determine whether an increased number of transrectal biopsy cores improves the accuracy of the biopsy Gleason score.
MATERIALS AND METHODS: This study included a total of 225 patients who were diagnosed as having prostate cancer by transrectal needle biopsy and subsequently underwent radical prostatectomy (RP) without neoadjuvant therapy. The rate of grading concordance between biopsy and RP specimens was analyzed by dividing these patients into 2 groups as follows: group A, 107 patients who underwent transrectal biopsy sampling of 9 cores or less (median 8 cores), and group B, 118 patients who underwent biopsy sampling of 10 cores or more (median 12 cores).
RESULTS: Concordance between the biopsy and RP Gleason scores in group A (53.3%) was significantly lower than that in group B (69.5%). Upgrading of the biopsy Gleason score in group A (38.3%) was significantly more frequent than that in group B (21.2%). Furthermore, these findings tended to be more prominent as the biopsy Gleason score was lower. Multivariate analysis identified the number of biopsy cores and percent of positive biopsy cores as independent predictors of accurate Gleason grading regardless of other parameters examined in this study.
CONCLUSION: These findings suggest that obtaining a greater number of biopsy cores contributes to improving the accuracy of the biopsy Gleason score for predicting the RP Gleason score; therefore, extended sampling of biopsy cores could provide optimal guidance to determine the therapeutic options in patients with prostate cancer. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025846     DOI: 10.1159/000109713

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  10 in total

1.  Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading.

Authors:  A Pichon; Y Neuzillet; H Botto; J-P Raynaud; C Radulescu; V Molinié; J-M Herve; T Lebret
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-10-06       Impact factor: 5.554

2.  Upgrading of Gleason score on radical prostatectomy specimen compared to the pre-operative needle core biopsy: an Indian experience.

Authors:  Rishi Nayyar; Prabhjot Singh; Narmada P Gupta; Ashok K Hemal; Prem N Dogra; Amlesh Seth; Rajeev Kumar
Journal:  Indian J Urol       Date:  2010 Jan-Mar

3.  Predictive factors of Gleason score upgrading in localized and locally advanced prostate cancer diagnosed by prostate biopsy.

Authors:  Seung Jin Moon; Sung Yul Park; Tchun Yong Lee
Journal:  Korean J Urol       Date:  2010-10-21

4.  Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancer.

Authors:  Stavros Sfoungaristos; Petros Perimenis
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

5.  [Active surveillance of localized prostate cancer. Significance of prostate core needle biopsies].

Authors:  J Rüschoff; P Middel; P Albers
Journal:  Pathologe       Date:  2008-09       Impact factor: 1.011

6.  Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study.

Authors:  Insang Hwang; Donghoon Lim; Young Beom Jeong; Seung Chol Park; Jun Hwa Noh; Dong Deuk Kwon; Taek Won Kang
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

7.  Is small prostate volume a predictor of Gleason score upgrading after radical prostatectomy?

Authors:  Mun Su Chung; Seung Hwan Lee; Dong Hoon Lee; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

8.  Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices.

Authors:  Franklin Lee; Henry Gottsch; William J Ellis; Lawrence D True; Daniel W Lin; Jonathan L Wright
Journal:  Adv Urol       Date:  2013-10-24

9.  Prediction models for prostate cancer to be used in the primary care setting: a systematic review.

Authors:  Mohammad Aladwani; Artitaya Lophatananon; William Ollier; Kenneth Muir
Journal:  BMJ Open       Date:  2020-07-19       Impact factor: 2.692

Review 10.  The use of prostate MR for targeting prostate biopsies.

Authors:  R Phelps Kelley; Ronald J Zagoria; Hao G Nguyen; Katsuto Shinohara; Antonio C Westphalen
Journal:  BJR Open       Date:  2019-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.